Medtronic company announced in China having unlimited remote function of implantable three cavity defibrillator Concerto series, this is domestic first wireless cardiac defibrillator, the Chinese cardiac pacing technology into the wireless age.
Medtronic Concerto CRT-D series products only 68 weight, based on the original product increased by wireless telemetry function and implantation of management optimization features, dramatically improved the dropper, program control head is no longer like conventional ICD implantation that need to be placed in the aseptic area, thereby reducing the time of implantation. Concerto CRT-D series can track and manage patients with heart failure symptoms, provide the necessary electric shocks to terminate the potential exception of heart rhythm; can also produce small pulse to synchronize shrink, help ventricle heart more effectively to the systemic blood supply. The device can also be in a specific time are automatically recorded in patients with cardiac rhythm, has accepted the treatment programme and other relevant data, this information may visit and provided to the doctor. At the same time, the Concerto also provides 24/7 all wireless monitoring of heart, a comprehensive assessment of patients with heart failure and arrhythmias. Experts say that prevention and treatment of cardiac and sudden death effective method is to install cardioverter defibrillator. Latest epidemiological survey, China's annual 54.4 million occurred of sudden cardiac death. Cardiac sudden unpredictable, extremely rapid disease progression, and occurred in hospital, the survival rate of treatment after the onset of only 1%. But from the 1990s clinical application start defibrillator technology, until now, my only approximately 500-bed cardiac defibrillator. Therefore, my heart defibrillator market while the potential maximum, but market remains to be seen in national sudden cardiac death disease prevention knowledge and related medical insurance policy adjustments.
No comments:
Post a Comment